Molecular insight into T cell exhaustion in hepatocellular carcinoma

Pharmacol Res. 2024 May:203:107161. doi: 10.1016/j.phrs.2024.107161. Epub 2024 Mar 29.

Abstract

Hepatocellular carcinoma is one of the leading causes of cancer-related mortality globally. The emergence of immunotherapy has been shown to be a promising therapeutic approach for hepatocellular carcinoma in recent years. It has been well known that T cell plays a key role in current immunotherapy. However, sustained exposure to antigenic stimulation within the tumor microenvironment may lead to T cell exhaustion, which may cause treatment ineffectiveness. Therefore, reversing T cell exhaustion has been an important issue for the clinical application of immunotherapy, and a comprehensive understanding of the intricacies surrounding T cell exhaustion and its underlying mechanisms is imperative for devising strategies to overcome the T cell exhaustion during treatment. In this review, we summarized the reported drivers of T cell exhaustion in hepatocellular carcinoma and delineate potential ways to reverse it. Additionally, we discussed the interplay among metabolic plasticity, epigenetic regulation, and transcriptional factors in exhausted T cells in hepatocellular carcinoma, and their implication for future clinical applications.

Keywords: Epigenetic regulation; Hepatocellular carcinoma; Immunotherapy; Metabolic pattern; T cell exhaustion; Transcription factors; Tumor microenvironment.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Carcinoma, Hepatocellular* / immunology
  • Carcinoma, Hepatocellular* / pathology
  • Epigenesis, Genetic
  • Humans
  • Immunotherapy
  • Liver Neoplasms* / immunology
  • Liver Neoplasms* / pathology
  • T-Cell Exhaustion
  • T-Lymphocytes* / immunology
  • Tumor Microenvironment* / immunology